This content is from: Corporate

CFIUS could block South Korean Magnachip deal

The Biden administration could assert jurisdiction over the transaction, even though both parties are based on foreign soil, because Magnachip has a research and sales presence in the US

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.

REQUEST ACCESS

Are you already an IFLR subscriber? Login here

Instant access to all of our content. Membership Options | 30 Day Trial